# PRESS RELEASE 2019

- # [FerGene Appoints David Meek Chief Executive Officer](/content/fergene-appoints-david-meek-chief-executive-officer/index.html)
  
By [pulse](/content/author/pulse/index.html) in [PRESS RELEASE 2019](/content/category/press-release-2019/index.html) on 18 December 2019  
  
FerGene, a new gene therapy company launched by Ferring Pharmaceuticals and Blackstone Life Sciences in November, today announced the appointment of David Meek as President and Chief Executive Officer …

- # [FerGene announces pivotal Phase 3 study of nadofaragene firadenovec](/content/fergene-announces-pivotal-phase-3-study-of-nadofaragene-firadenovec/index.html)
  
By [pulse](/content/author/pulse/index.html) in [PRESS RELEASE 2019](/content/category/press-release-2019/index.html) on 05 December 2019  
  
FerGene, a new gene therapy company formed by Ferring Pharmaceuticals and Blackstone Life Sciences, announced today positive results from the pivotal Phase 3 clinical trial evaluating nadofaragene firadenovec …

- # [Ferring and Blackstone Life Sciences invest over $570 million USD in novel gene therapy for bladder cancer patients](/content/ferring-and-blackstone-life-sciences-invest-over-570-million-usd-in-novel-gene-therapy-for-bladder-cancer-patients/index.html)
  
By [pulse](/content/author/pulse/index.html) in [PRESS RELEASE 2019](/content/category/press-release-2019/index.html) on 25 November 2019  
  
Ferring and Blackstone Life Sciences invest over $570 million USD in novel…

- # [Heat-stable carbetocin has been added to the WHO Essential Medicines List for the prevention of excessive bleeding after childbirth](/content/heat-stable-carbetocin-has-been-added-to-the-who-essential-medicines-list-for-the-prevention-of-excessive-bleeding-after-childbirth/index.html)
  
By [pulse](/content/author/pulse/index.html) in [PRESS RELEASE 2019](/content/category/press-release-2019/index.html) on 09 July 2019  
  
Ferring Pharmaceuticals today welcomes the World Health Organization’s (WHO) addition of heat-stable carbetocin to the WHO Model List of Essential Medicines (EML)…

- # [Ferring announces changes to Executive Committee](/content/ferring-announces-changes-to-executive-committee/index.html)
  
By [pulse](/content/author/pulse/index.html) in [PRESS RELEASE 2019](/content/category/press-release-2019/index.html) on 01 July 2019  
  
Ferring Pharmaceuticals announced today that Lars Peter Brunse is retiring from his role as Executive Vice President and Chief Production Officer. Armin Metzger, previously Senior Vice President, Head of Global Pharmaceutical R&D, has been appointed

- # [Ferring collaboration with digital health innovators WOOM aims to help more people build families faster](/content/ferring-collaboration-with-digital-health-innovators-woom-aims-to-help-more-people-build-families-faster/index.html)
  
By [pulse](/content/author/pulse/index.html) in [PRESS RELEASE 2019](/content/category/press-release-2019/index.html) on 19 June 2019  
  
Ferring Pharmaceuticals and WOOM today announced a collaboration, which aims to improve and shorten the fertility journeys of the one in six couples who have difficulty conceiving…

- # [Ferring, Rebiotix and Karolinska Institutet extend collaboration to research next generation of microbiome treatments](/content/ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments/index.html)
  
By [pulse](/content/author/pulse/index.html) in [PRESS RELEASE 2019](/content/category/press-release-2019/index.html) on 22 January 2019  
  
Ferring Pharmaceuticals and Karolinska Institutet announced today a five-year extension of their collaboration to explore the potential of the human microbiome in reproductive medicine and women’s health and gastroenterology.